Fredun Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 814.81 million compared to INR 688.44 million a year ago. Revenue was INR 819.85 million compared to INR 703.23 million a year ago. Net income was INR 39.36 million compared to INR 31.53 million a year ago. Basic earnings per share from continuing operations was INR 8.4 compared to INR 7.11 a year ago.
For the six months, sales was INR 1,427.08 million compared to INR 1,169.69 million a year ago. Revenue was INR 1,440.31 million compared to INR 1,187.4 million a year ago. Net income was INR 63.38 million compared to INR 40.97 million a year ago. Basic earnings per share from continuing operations was INR 13.56 compared to INR 10.27 a year ago.